|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 21/02 | |
| C07H 21/04 | |||
| A01N 61/00 | |||
| A01N 37/18 | |||
| A61K 31/00 | |||
| A61K 38/17 | |||
| A61K 35/14 | |||
| A61K 38/13 | |||
| A61K 45/06 |
| (11) | Number of the document | 2789625 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14167252.7 |
| Date of filing the European patent application | 2007-08-16 | |
| (97) | Date of publication of the European application | 2014-10-15 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 838812 P | 2006-08-18 | US | |
| 927377 P | 2007-05-04 | US |
| (72) |
Nicolette, Charles, US
Brand, Stephen, US
Zhong, Zhen, CA
Wang, Hao, CA
Arp, Jacqueline, CA
Ramcharran, Siobhan, CA
Baroja, Mirin Lorea, CA
|
| (73) |
Argos Therapeutics, Inc.,
4233 Technology Drive, Durham, NC 27704,
US
|
| (54) | Use of soluble CD83 for perfusing a tissue for transplantation |
| Use of soluble CD83 for perfusing a tissue for transplantation |